Published in Nature Medicine · View the paper (DOI)
Researchers funded by Neuroendocrine Tumor Research Foundation (NETRF) discover molecular information that can help predict the recurrence of non-functional pancreatic neuroendocrine tumors. The study identifies two new subtypes of pNETs, one with a high risk of recurrence and another with an excellent prognosis.
Coverage from 2 institutions